Clinical Trial Update: Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunosuppressive regimens for progression of arteriosclerosis in renal transplant patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis

Snippet

Sponsor: Dianet Dialysis Centers | Conditions: Renal Transplantation | Phase 4 | Status: TERMINATED